1,3- bis((2'- (((acetoxymethyl)oxy)carbonyl)chromon- 5'- yl)oxy)- 2- hydroxypropane

cell-permeable cromoglycate derivative which inhibits type I FC(epsilon) receptor mediated Ca2+ influx & mediator secretion in rat mucosal mast cells; structure given in first source

Also Known As:

CG-AM; bis(acetoxymethyl)cromoglycate

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrans: 130
    - Benzopyrans: 195
      - Chromones: 159
        Cromolyn Sodium: 1886
        1,3-bis((2'-(((acetoxymethyl)oxy)carbonyl)chromon-5'-yl)oxy)-2-hydroxypropane: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 195
      - Chromones: 159
        Cromolyn Sodium: 1886
        1,3-bis((2'-(((acetoxymethyl)oxy)carbonyl)chromon-5'-yl)oxy)-2-hydroxypropane: 1

Experts

1.	Novak, Josef F: 1 article (03/2005)
2.	Trnka, Frantisek: 1 article (03/2005)

Related Diseases

1.	Neoplasms (Cancer) 03/01/2005 - "Elevated levels of endostatin and angiostatin appear in the blood of TG/CG/AM-treated tumor-bearing mice, but not in tumor mice treated with the vehicle alone or in proenzyme-treated tumor-free mice. "

Related Drugs and Biologics

1.	Endostatins
2.	Angiostatins
3.	Enzyme Precursors (Zymogens)